Erle T. Mast, Director at Somaxon Pharmaceuticals, Inc. (SOMX), sold 5,000 shares at $0.85 ($4K) on 2011-10-03, disclosed to the SEC on 2011-10-04.
Scheduled sale ($4k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SNNA | BUY | 2017-08-01 | $101K | — | Filing → |
| CLVS | SELL | 2015-11-03 | $317K | — | Filing → |
| CLVS | SELL | 2015-10-02 | $271K | — | Filing → |